Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Long-acting cabotegravir and rilpivirine injections were more effective than daily oral regimens, according to ViiV Healthcare.
Antiretroviral treatment that halts HIV replication can prevent or reverse immune deficiency.
Women living with HIV can have healthy HIV-free babies, but this takes planning.
Researchers developed an extended-release injectable formulation of the most widely prescribed antiretroviral regimen worldwide.
Dovato blister packs are designed to be small, discreet and portable for people living with HIV, says drugmaker ViiV Healthcare.
Each day of delay during primary HIV infection lowered the odds of reaching a CD4 count above 900.
Researchers enrolled more than 4,500 cisgender men and trans women.
The integrase inhibitor has a high barrier to resistance, but it can fail if used alone or with partner drugs that are not fully active.
An extended-release formulation of tenofovir, lamivudine and dolutegravir maintained effective drug levels for a month.
This year’s most widely viewed stories focused on HIV cure and vaccine news, long-acting treatment and coexisting conditions.
The pandemic slowed improvements in viral suppression and worsened health disparities, hampering efforts to reach HIV elimination goals.
“Ending AIDS is possible but only if we take bold action.”
Infants treated within the first days of life can have a low viral reservoir, but most don’t receive antivirals so soon in the real world.
New data and campaigns show progress in the fight against HIV. However, substantial and widening disparities persist.
“Let communities lead” in the fight against HIV, urges UNAIDS on the eve of World AIDS Day, noting that many groups lack critical funding.
New interactive data and maps show that Black Americans remain disproportionately impacted by the HIV epidemic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.